The American Society of Clinical Oncology (ASCO) previously published evidencebased
guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC)[1]. ASCO …

Purpose: To compare the diagnostic accuracy of computed tomography (CT) and positron
emission tomography (PET) with 18-fluorodeoxyglucose (FDG) for mediastinal staging in …

Purpose The phase III PROCLAIM study evaluated overall survival (OS) of concurrent
pemetrexed-cisplatin and thoracic radiation therapy (TRT) followed by consolidation …

Background We compared the diagnostic accuracy of integrated positron-emission
tomography (PET) and computed tomography (CT) with that of CT alone, that of PET alone …

[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …

Historically, anatomical CT and MR images were used to delineate the gross tumour
volumes (GTVs) for radiotherapy treatment planning. The capabilities offered by modern …

Functional imaging with positron emission tomography (PET) is playing an increasingly
important role in the diagnosis and staging of malignant disease, image-guided therapy …

Purpose Under Medicare's Coverage with Evidence Development policy, positron emission
tomography (PET)/computed tomography (CT) and PET became covered services for …

Recently, the thymidine analog 3′-deoxy-3′-18F-fluorothymidine (FLT) was suggested for
imaging tumoral proliferation. In this prospective study, we examined whether 18F-FLT …

PET with 18F-FDG has been used in radiation treatment planning for non–small cell lung
cancer (NSCLC). Thresholds of 15%–50% the maximum standardized uptake value …